Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough

NewsWed, 19 Aug 2026 14:09:39 UTC21 days ago

Moderna (MRNA) stock exploded over 100% in Wednesday pre-market trading, hitting $122.51 after the company and Merck (MRK) reported the first positive Phase 3 result for a personalized mRNA cancer vaccine.

The gain is pre-market only for now. Moderna last closed at $62.96 on Tuesday, and regular trading in New York had not yet opened at the time of writing.

Moderna Stock Rally. Source: Yahoo Finance

Follow us on X to get the latest news as it happens

A First for Personalized mRNA Cancer Therapy

The Phase 3 INTerpath-001 trial tested a bold idea. Doctors read the mutations in a patient's tumor. Moderna then builds a custom mRNA shot for that one person.

Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination… pic.twitter.com/v4DjH0r823
- Moderna (@moderna_tx) August 19, 2026

Each shot encodes up to 34 tumor targets, known as neoantigens. In effect, it teaches the immune system exactly what to hunt.

… Continue reading the full article at the original source below.

Read from Source · beincrypto.com ↗

This content is automatically aggregated. Full credit goes to the original publisher (beincrypto.com).

Moderna Stock Explodes Over 100% After Cancer Vaccine Breakthrough

A First for Personalized mRNA Cancer Therapy

Related

Canadian companies’ shares fall after Trump threatens to ban their products from US federal contracts

Trump discusses peace with Putin, optimistic about Ukraine deal

Ronald Araujo records first assist for Liverpool on UCL debut

Legal battles may reshape congressional maps for 2026 midterms